Intervju med SDS VD Tommy Eriksson
Comment
2024-10-07
Comment on Pharma Equity Group’s Directed Share Issue to a Premium
Equity research report
2024-09-05
ODI Pharma
2024-08-29
Comment on ODI Pharma’s Quarterly Report
STENOCARE Q2-24
2024-08-22
Comment on STENOCARE’s Q2-report Report 2024